Full Text View
Tabular View
No Study Results Posted
Related Studies
Trial of Dasatinib in Subjects With Advanced Cancers Harboring DDR2 Mutation or Inactivating B-RAF Mutation
This study has been completed.
Study NCT01514864   Information provided by Bristol-Myers Squibb

First Received on January 18, 2012.   Last Updated on August 28, 2014   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Additional conditions recognized in this trial
More general conditions related to this trial
Interventions listed in this trial
More general drug interventions related to this trial
Sponsors listed in this trial